Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutati…

In breve

<article class="story default clearfix">

<h2> <a href="https://www.middleeasteye.net/news/no-reshape-algeria-prepares-legislative-elections-few-hold-hope-for-change" rel="bookmark"> <span class="field field-title">‘No reshape’: Algeria prepares for elections but f

Contesto

Scientists finally crack an “undruggable” pancreatic cancer target and nearly double survival For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something many scientists once thought couldn't be done. In a major clinical trial, the treatment nearly doubled survival for patients with advanced disease and reduced the risk of death by 60%. According to the collected source material from www.sciencedaily.com, For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something many scientists once thought couldn't be done. In a major clinical trial, the treatment nearly doubled survival for patients with advanced…

Lettura DEO

Verdetto: publish
Confidenza: 82/100

Deterministic fallback judge output. Libre judge fallback via DeepSeek Gamma.

Categoria: cronaca
Entità: Scientists